Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer Letters

• Publication date

  2010-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.canlet.2010.02.011PMID 20207071
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The NF-κB activation pathways, emerging molecular targets for cancer prevention and therapy

  2010cited by this paper
• IKKβ-mediated nuclear factor-κB activation attenuates smac mimetic–induced apoptosis in cancer cells

  2009cited by this paper
• FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt.

  2009cited by this paper
• Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors.

  2009cited by this paper
• 3,3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer.

  2009cited by this paper
• Activation of the PI3K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2a

  2009cited by this paper
• Is NF-κB a good target for cancer therapy? Hopes and pitfalls

  2009cited by this paper
• Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug

  2009cited by this paper
• Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion.

  2009cited by this paper
• Blockage of NF‐κB by IKKβ‐ or RelA‐siRNA rather than the NF‐κB super‐suppressor IκBα mutant potentiates adriamycin‐induced cytotoxicity in lung cancer cells

  2008cited by this paper
• Phosphoinositide 3‐kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death

  2008cited by this paper
• AKT Is Activated in an Ataxia-Telangiectasia and Rad3-Related-Dependent Manner in Response to Temozolomide and Confers Protection against Drug-Induced Cell Growth Inhibition

  2008cited by this paper
• Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells

  2008cited by this paper
• Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1.

  2008cited by this paper
• Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.

  2007cited by this paper
• Sensitization of TNF-induced cytotoxicity in lung cancer cells by concurrent suppression of the NF-kappaB and Akt pathways.

  2007cited by this paper
• Inactivation of NF-κB by 3,3′-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells

  2007cited by this paper
• Signals from within: the DNA-damage-induced NF-kappaB response.

  2006cited by this paper
• NF-kappaB activation is required for cisplatin-induced apoptosis in head and neck squamous carcinoma cells.

  2006cited by this paper
• Signals from within: the DNA-damage-induced NF-κB response

  2006cited by this paper
• 17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway.

  2006cited by this paper
• NF‐κB activation is required for cisplatin‐induced apoptosis in head and neck squamous carcinoma cells

  2006cited by this paper
• Role of Dioxin Response Element and Nuclear Factor-κB Motifs in 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Mediated Regulation of Fas and Fas Ligand Expression

  2006cited by this paper
• Overexpression of Cyclin D1 Promotes Tumor Cell Growth and Confers Resistance to Cisplatin-Mediated Apoptosis in an Elastase-myc Transgene–Expressing Pancreatic Tumor Cell Line

  2005cited by this paper
• Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation

  2005cited by this paper
• Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.

  2005cited by this paper
• Nuclear factor-kappaB: the enemy within.

  2004cited by this paper
• NF-κB functions as a tumour promoter in inflammation-associated cancer

  2004cited by this paper
• NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis.

  2004cited by this paper
• Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression.

  2004cited by this paper
• Chemoresistance: impact of nuclear factor (NF)-kappaB inhibition by small interfering RNA. Commentary re J. Guo et al., Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the NF-kappaB p65 subunit. Clin Cancer Res 2004;10:3333-3341.

  2004cited by this paper
• NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis

  2004cited by this paper
• Signaling to NF-kappaB.

  2004cited by this paper
• NF-kappaB functions as a tumour promoter in inflammation-associated cancer.

  2004cited by this paper
• Dual role of NF-kappaB in apoptosis of THP-1 cells during treatment with etoposide and lipopolysaccharide.

  2004cited by this paper
• Nuclear factor-κB: The enemy within

  2004cited by this paper
• Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression

  2004cited by this paper
• Chemoresistance: Impact of Nuclear Factor (NF)-κB Inhibition by Small Interfering RNA

  2004cited by this paper
• Membrane Transporters and Channels

  2004cited by this paper
• The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation.

  2003cited by this paper
• The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

  2002cited by this paper
• NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase

  1999cited by this paper

• Targeting Oxidative Stress in Carcinogenesis: Oleanolic Acid and Its Molecular Pathways

  2026cites this paper
• Disulfiram/Cu targeting FOXO6 modulates sensitivity of hepatocellular carcinoma to lenvatinib via disrupt choline metabolic.

  2024cites this paper
• Metformin synergistically enhances the antitumour activity of Lenvatinib in hepatocellular carcinoma by altering AKT‐FOXO3 signalling pathway

  2023cites this paper
• Histone H4 expression is cooperatively maintained by IKKβ and Akt1 which attenuates cisplatin-induced apoptosis through the DNA-PK/RIP1/IAPs signaling cascade

  2017cites this paper
• NF-κB Blockers Gifted by Mother Nature: Prospectives in Cancer Cell Chemosensitization.

  2016cites this paper
• Radiolabeled Polymeric Nanoconstructs Loaded with Docetaxel and Curcumin for Cancer Combinatorial Therapy and Nuclear Imaging

  2015cites this paper
• Upstream regulation of yeast TOR complexes

  2015cites this paper
• Strategies and validation for siRNA-based therapeutics for the reversal of multi-drug resistance in cancer.

  2014cites this paper
• Subverting ER-Stress towards Apoptosis by Nelfinavir and Curcumin Coexposure Augments Docetaxel Efficacy in Castration Resistant Prostate Cancer Cells

  2014cites this paper
• GAP161 targets and downregulates G3BP to suppress cell growth and potentiate cisplaitin‐mediated cytotoxicity to colon carcinoma HCT116 cells

  2012cites this paper
• Concurrent blockade of NF-&kgr;B and Akt pathways potentiates cisplatin’s antitumor activity in vivo

  2012cites this paper
• In brief

  2011cites this paper
• Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo

  2011cites this paper
• Blocking NF-κB and Akt by Hsp90 inhibition sensitizes Smac mimetic compound 3-induced extrinsic apoptosis pathway and results in synergistic cancer cell death

  2010cites this paper